MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, KALV has $328,917K in assets. $348,569K in debts. $213,768K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
516.64%
Quick Ratio
510.06%
Cash Ratio
351.49%
Debt to Asset Ratio
105.97%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Royalty obligation - net of curr...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-07-31
Cash and cash equivalents
213,768 229,342 243,497 124,304
Marketable securities
71,262 70,872 65,661 67,161
Accounts receivable, net
9,897 2,593 5,779 1,926
Inventory
4,002 3,428 458 -
Research and development tax credit receivable
7,430 6,200 1,343 561
Prepaid expenses and other current assets
7,846 7,712 8,488 11,944
Total current assets
314,205 320,147 325,226 205,896
Property and equipment, net
2,841 3,034 3,190 2,067
Right of use assets
9,421 9,825 9,096 5,165
Other assets
2,450 2,369 2,419 2,377
Total assets
328,917 335,375 339,931 215,505
Accounts payable
8,045 8,268 8,074 5,869
Accrued expenses and other current liabilities
34,022 33,897 20,767 18,971
Deferred revenue - current portion
833 -11,512 11,413
Lease liability - current portion
1,691 1,621 1,429 2,122
Royalty obligation - current portion
16,226 13,569 3,287 -
Total current liabilities
60,817 57,355 45,069 38,375
Deferred revenue - net of current portion
21,357 11,714 --
Lease liability - net of current portion
10,411 10,727 9,128 4,019
Royalty obligation - net of current portion
116,583 119,063 129,707 -
Royalty obligation
---132,321
Convertible notes
139,401 139,227 139,028 -
Total long-term liabilities
---136,340
Total liabilities
348,569 338,086 322,932 -
Common stock, 0.001 par value 100,000,000 shares authorized at march 31, 2026 and december 31, 2025 51,237,509 and 50,900,777 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
51 51 50 50
Additional paid-in capital
773,594 767,061 762,776 760,393
Accumulated deficit
-786,181 -762,694 -739,098 -713,266
Accumulated other comprehensive loss
-7,116 -7,129 -6,729 -6,387
Total stockholders' deficit
-19,652 -2,711 16,999 40,790
Total liabilities and stockholders' deficit
328,917 335,375 339,931 215,505
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$213,768K Marketable securities$71,262K Accounts receivable, net$9,897K Prepaid expenses andother current assets$7,846K Research and developmenttax credit...$7,430K Inventory$4,002K Total current assets$314,205K Right of use assets$9,421K Property and equipment,net$2,841K Other assets$2,450K Total assets$328,917K Accumulated deficit-$786,181K Accumulated othercomprehensive loss-$7,116K Total liabilities andstockholders' deficit$328,917K Total stockholders'deficit-$19,652K Additional paid-in capital$773,594K Common stock, 0.001 parvalue 100,000,000...$51K Total liabilities$348,569K Convertible notes$139,401K Royalty obligation - netof current portion$116,583K Total currentliabilities$60,817K Deferred revenue - net ofcurrent portion$21,357K Lease liability - netof current portion$10,411K Accrued expenses andother current...$34,022K Royalty obligation -current portion$16,226K Accounts payable$8,045K Lease liability -current portion$1,691K Deferred revenue -current portion$833K

KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals, Inc. (KALV)